Timothy Jinks BS, MA, PhD

Timothy Jinks is the Head of Drug-Resistant Infections Priority Program leading Wellcome Trust’s strategic plan to address antimicrobial resistance. In his preceding role in Wellcome’s Innovations Division, he was responsible for a portfolio of over a dozen early stage product development projects covering therapeutics, diagnostic and devices spanning across therapeutic areas such as infectious diseases and oncology. He also serves as Wellcome Trust’s Non-Executive Director of Reviral Ltd. Prior to joining the Trust in 2012, he has over a decade of industry experience, most recently as a consultant providing business development, licensing and commercial research services.